Pei Hui, PhD, MD

Professor of Pathology; Director, Gynecologic Pathology; Clinical Director, Molecular Diagnostics Laboratory; Director, Gynecologic and Breast Pathology Fellowship Program.

Physician Biography

Pei Hui, M.D., Ph.D. obtained his medical degree from Xi’an Jiaotong University (China) and PhD degree from SUNY. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital, followed by Oncological Pathology Fellowship training at MSKCC. He has joined the pathology faculty at Yale since 2001. Dr. Hui is a board certified surgical pathologist with clinical specialty areas including gynecological pathology and molecular diagnostics. As director of Yale Gynecological Pathology Service, he leads a world-class diagnostic service of providing tissue evaluation of all types of ovarian, uterine and cervical cancers. Dr. Hui has particular clinical expertise in the diagnostic workup of gestational trophoblastic disease (GTD). He serves on the editorial boards of International Journal of Gynecological Pathology, Human Pathology, American Journal of Clinical Pathology and Journal of Clinical Pathology. He has produced over 160 publications and authored three pathology textbooks including Cytology and Surgical Pathology of Gynecologic Neoplasms, Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology, and Atlas of Intraoperative Consultation of Gynecologic Pathology. He is the responsible author for the current WHO classification of gestational trophoblastic disease. Dr. Hui serves on the Board of Directors of The International Society of Gynecological Pathologists (ISGyP).

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: MD to MD Consult

Patient Care Organizations

Pathology: Medical & Surgical Pathology: Gynecological Pathology | Molecular & Genomic Pathology

Yale Cancer Center: Gynecologic Oncology Program

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Anatomic & Clinical Pathology AB of Pathology (2000)

  • Molecular Genetic Pathology AB of Pathology (2003)

Clinical Trials

Conditions Study Title
Cervix Uteri Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy
Corpus Uteri Lymph Node Mapping in Patients With Endometrial Cancer

Edit this profile